These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 29032944)

  • 21. Subcutaneous vs intravenous rituximab in patients with non-Hodgkin lymphoma: a time and motion study in the United Kingdom.
    Rule S; Collins GP; Samanta K
    J Med Econ; 2014 Jul; 17(7):459-68. PubMed ID: 24720836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice.
    Harivardhan Reddy L; Sharma RK; Chuttani K; Mishra AK; Murthy RS
    J Control Release; 2005 Jul; 105(3):185-98. PubMed ID: 15921775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraindividual comparison of pharmacokinetics of insulin after intravenous, portal, subcutaneous and peritoneal administration.
    Fritze K; Fischer U; Freyse EJ; Besch W
    Exp Clin Endocrinol; 1988 Mar; 92(3):297-306. PubMed ID: 3075553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled trial.
    Carratalà J; Garcia-Vidal C; Ortega L; Fernández-Sabé N; Clemente M; Albero G; López M; Castellsagué X; Dorca J; Verdaguer R; Martínez-Montauti J; Manresa F; Gudiol F
    Arch Intern Med; 2012 Jun; 172(12):922-8. PubMed ID: 22732747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcutaneous administration of anticancer agents.
    Leveque D
    Anticancer Res; 2014 Apr; 34(4):1579-86. PubMed ID: 24692685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Satisfaction of Breast Cancer patients treated by chemotherapy outpatient clinics: Results of the TemporELLES survey].
    Lerebours F; Saltel P; Béthune-Volters A; Nallet G; Bourdat P; Vesin-Etterlen F; Zernik N; Flinois A
    Bull Cancer; 2015 Apr; 102(4):316-23. PubMed ID: 25818929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics, safety, and efficacy of subcutaneous versus intravenous rituximab plus chemotherapy as treatment for chronic lymphocytic leukaemia (SAWYER): a phase 1b, open-label, randomised controlled non-inferiority trial.
    Assouline S; Buccheri V; Delmer A; Gaidano G; Trneny M; Berthillon N; Brewster M; Catalani O; Li S; McIntyre C; Sayyed P; Badoux X
    Lancet Haematol; 2016 Mar; 3(3):e128-38. PubMed ID: 26947201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The dependence of the antineoplastic activity of serotonin on dose and route of administration].
    Mal'tseva LF
    Vopr Onkol; 1966; 12(3):67-71. PubMed ID: 5991964
    [No Abstract]   [Full Text] [Related]  

  • 29. Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study.
    Pivot X; Gligorov J; Müller V; Barrett-Lee P; Verma S; Knoop A; Curigliano G; Semiglazov V; López-Vivanco G; Jenkins V; Scotto N; Osborne S; Fallowfield L;
    Lancet Oncol; 2013 Sep; 14(10):962-70. PubMed ID: 23965225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreasing laboratory turnaround time and patient wait time by implementing process improvement methodologies in an outpatient oncology infusion unit.
    Gjolaj LN; Gari GA; Olier-Pino AI; Garcia JD; Fernandez GL
    J Oncol Pract; 2014 Nov; 10(6):380-2. PubMed ID: 25336080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcutaneous administration of fentanyl in childbirth: an observational study on the clinical effectiveness of fentanyl for mother and neonate.
    Fleet J; Jones M; Belan I
    Midwifery; 2014 Jan; 30(1):36-42. PubMed ID: 23523191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between lethal toxicity in oral administration and injection to mice: effect of exposure routes.
    Wang Y; Ning ZH; Tai HW; Long S; Qin WC; Su LM; Zhao YH
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):205-12. PubMed ID: 25558060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Examination of the usefulness of the pharmacists' outpatient clinic for treatment with oral molecule-targeting drugs].
    Aimono Y; Nemoto M; Sato W; Saito Y; Aoyama Y; Joko F; Maruyama T; Kamoshida T
    Gan To Kagaku Ryoho; 2013 Jul; 40(7):901-5. PubMed ID: 23863732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of subcutaneous and intravenous administration of trastuzumab: a phase I/Ib trial in healthy male volunteers and patients with HER2-positive breast cancer.
    Wynne C; Harvey V; Schwabe C; Waaka D; McIntyre C; Bittner B
    J Clin Pharmacol; 2013 Feb; 53(2):192-201. PubMed ID: 23436264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of route of EPO administration on hemodialysis arteriovenous vascular access failure: a randomized controlled trial.
    Lee YK; Koo JR; Kim JK; Park II; Joo MH; Yoon JW; Noh JW; Vaziri ND
    Am J Kidney Dis; 2009 May; 53(5):815-22. PubMed ID: 19324483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Societal cost of subcutaneous and intravenous trastuzumab for HER2-positive breast cancer - An observational study prospectively recording resource utilization in a Swedish healthcare setting.
    Olofsson S; Norrlid H; Karlsson E; Wilking U; Ragnarson Tennvall G
    Breast; 2016 Oct; 29():140-6. PubMed ID: 27498127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced Hospital Duration of Stay Associated with Revised Emergency Department-Intensive Care Unit Admission Policy: A before and after Study.
    McCoy JV; Gale AR; Sunderram J; Ohman-Strickland PA; Eisenstein RM
    J Emerg Med; 2015 Dec; 49(6):893-900. PubMed ID: 26409680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does Intravenous Midazolam Dose Influence the Duration of Recovery Room Stay Following Outpatient Third Molar Surgery?
    Ettinger KS; Jacob AK; Viozzi CF; Van Ess JM; Fillmore WJ; Arce K
    J Oral Maxillofac Surg; 2015 Dec; 73(12):2287-93. PubMed ID: 26183011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Patients' satisfaction and waiting time in oncology day care centers in Champagne-Ardenne].
    Debreuve-Theresette A; Jovenin N; Stona AC; Kraïem-Leleu M; Burde F; Parent D; Hettler D; Rey JB
    Rev Epidemiol Sante Publique; 2015 Dec; 63(6):381-6. PubMed ID: 26525094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse events from targeted therapies in advanced renal cell carcinoma: the impact on long-term use.
    Kirkali Z
    BJU Int; 2011 Jun; 107(11):1722-32. PubMed ID: 21251188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.